Glycopyrronium requirements for antagonism of the muscarinic side effects of edrophonium†

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have compared, in 60 adult patients, the cardiovascular effects of glycopyrronium 5 μg kg-1 and 10 μg kg-1 given either simultaneously or 1 min before edrophonium 1 μg kg-1. Significant differences between the four groups were detected (P < 0.001). Both groups receiving 10 μg kg-1 showed increases in heart rate of up to 30 beat min-1 (95% confidence limits 28-32 beat min-1). Use of glycopyrronium 5 μg kg-1 provided greater cardiovascular stability and, given 1 min before the edrophonium, was sufficient to minimize early, edrophonium-induced bradycardias. This low dose of glycoprronium provided good control of oropharyngeal secretions. © 1989 British Journal of Anaesthesia.

Cite

CITATION STYLE

APA

Dodd, P., Day, S. J., Goldhill, D. R., Macleod, D. M., Withington, P. S., & Yate, P. M. (1989). Glycopyrronium requirements for antagonism of the muscarinic side effects of edrophonium†. British Journal of Anaesthesia, 62(1), 77–81. https://doi.org/10.1093/bja/62.1.77

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free